Wells Fargo Starts Kestra Medical Technologies (KMTS) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
BofA Securities Starts Kestra Medical Technologies (KMTS) at Buy
March 31, 2025 6:52 AM EDTBofA Securities analyst Travis Steed initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Buy rating and a price target of $30.00.
For an analyst ratings summary and ratings history on Kestra Medical Technologies... More
Wolfe Research Starts Kestra Medical Technologies (KMTS) at Outperform
March 31, 2025 5:19 AM EDTWolfe Research analyst Mike Polark initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Outperform rating and a price target of $29.00.
For an analyst ratings summary and ratings history on Kestra Medical Technologies... More
Goldman Sachs Starts Kestra Medical Technologies (KMTS) at Neutral
March 31, 2025 5:12 AM EDTGoldman Sachs analyst David Roman initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Neutral rating and a price target of $24.00.
The analyst comments "We initiate coverage on the shares of Kestra Medical Technologies (KMTS) with a Neutral rating and a 12-month price target... More
Piper Sandler Starts Kestra Medical Technologies (KMTS) at Overweight
March 31, 2025 3:55 AM EDTPiper Sandler analyst Matt O\'Brien initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Overweight rating and a price target of $27.00.
The analyst comments: "We are initiating Kestra Medical with an OW rating and $27 price target. The company boasts a unique, wearable... More
Stifel Starts Kestra Medical Technologies (KMTS) at Buy
March 31, 2025 2:07 AM EDTStifel analyst Rick Wise initiates coverage on Kestra Medical Technologies (NASDAQ: KMTS) with a Buy rating and a price target of $28.00.
The analyst comments: "We are initiating coverage of Kestra (KMTS) with a Buy rating and $28 target price. This assumes KMTS trades at 9x our CY2027E... More



